Institutional Ownership
Outlook Therapeutics Inc
CUSIP 69012T305COMOTLKQ1 2026
13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
50.3%
Max % of class reported
Institutional Holders
51
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
21 filings · latest Feb 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2026 | Sphera Funds Management Ltd. | 13G/A | 4.7% | 3.15M | SEC |
| 2 | Oct 21, 2025 | Empery Asset Management, LP | 13G/A | 5.0% | 2.33M | SEC |
| 3 | Aug 14, 2025 | Tang Capital Management, LLC | 13G/A | 3.4% | 1.50M | SEC |
| 4 | Aug 14, 2025 | Great Point Partners, LLC | 13G/A | 5.0% | 2.22M | SEC |
| 5 | Jul 31, 2025 | Empery Asset Management, LP | 13G | 7.6% | 3.20M | SEC |
| 6 | May 28, 2025 | Gms Ventures &Amp; Investments | 13D/A | 50.3% | — | SEC |
| 7 | May 15, 2025 | Tang Capital Management, LLC | 13G/A | 5.6% | 1.90M | SEC |
| 8 | May 15, 2025 | Great Point Partners, LLC | 13G/A | 6.4% | 2.22M | SEC |
| 9 | Apr 10, 2025 | Sphera Funds Management Ltd. | 13G/A | 7.5% | 2.57M | SEC |
| 10 | Mar 12, 2025 | Gms Ventures &Amp; Investments | 13D/A | 41.6% | — | SEC |
11 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Outlook Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 4.17M | $857.8K |
| 2 | Geode Capital Management, LLC | 603.6K | $124.2K |
| 3 | Gilpin Wealth Management, LLC | 600.2K | $123.5K |
| 4 | Blackrock, Inc. | 477.5K | $98.3K |
| 5 | Commonwealth Equity Services, LLC | 470.0K | $96.7K |
| 6 | Warberg Asset Management LLC | 275.0K | $56.4K |
| 7 | Renaissance Technologies LLC | 255.2K | $52.5K |
| 8 | Nine Masts Capital Ltd | 232.5K | $47.9K |
| 9 | Connective Capital Management, LLC | 200.0K | $41.2K |
| 10 | State Street Corp | 163.1K | $33.6K |